The provided text contains only publication metadata and no abstract, precluding the extraction of study results regarding endothelial protection by converting enzyme inhibitors.
Journal Article Endothelial protection by converting enzyme inhibitors Get access Gabriele Wiemer, Gabriele Wiemer Hoechst AG, SBU Cardiovascular Agents, H821, D-65926 Frankfurt/Main, Germany: G Wiemer, B A Schölkens, W Linz. Correspondence to Professor Wiemer. Search for other works by this author on: Oxford Academic PubMed Google Scholar Bernward A Schölkens, Bernward A Schölkens Hoechst AG, SBU Cardiovascular Agents, H821, D-65926 Frankfurt/Main, Germany: G Wiemer, B A Schölkens, W Linz. Search for other works by this author on: Oxford Academic PubMed Google Scholar Wolfgang Linz Wolfgang Linz Hoechst AG, SBU Cardiovascular Agents, H821, D-65926 Frankfurt/Main, Germany: G Wiemer, B A Schölkens, W Linz. Search for other works by this author on: Oxford Academic PubMed Google Scholar Cardiovascular Research, Volume 28, Issue 2, February 1994, Pages 166–172, https://doi.org/10.1093/cvr/28.2.166 Published: 01 February 1994 Article history Received: 12 May 1993 Accepted: 09 August 1993 Published: 01 February 1994
Wiemer et al. (Tue,) reported a other. Converting enzyme inhibitors was evaluated. The provided text contains only publication metadata and no abstract, precluding the extraction of study results regarding endothelial protection by converting enzyme inhibitors.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: